A study for safety evaluation of Long-Term intake of Probiotics -A Randomized, Double-Blind, Placebo-Controlled trial- - A study for safety evaluation of Long-Term intake of Probiotics -A Randomized, Double-Blind, Placebo-Controlled trial

KSO Corporation0 个研究点目标入组 40 人开始时间: 2024年4月5日最近更新: 2024年9月2日

试验速览

暂无简介。

•1.Subjects who have a history of serious illness. 2.Subjects who are under treatment with medication for chronic diseases. 3.Subjects who are unable to discontinue foods or supplements containing lactic acid bacteria, bifidobacteria, oligosaccharides, etc. during the study period. 4.Subjects who have digestive tract diseases that affect digestion and absorption, and have had a history of gastrointestinal surgery (excluding appendicitis). 5.Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. 6.Subjects who are planning to participate in other clinical studies. 7.Subjects with a history of drug allergies or severe food allergies. 8.Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study period. 9.Heavy alcohol drinkers (average of more than 20g of alcohol/day in terms of pure alcohol). 10.Excessive smokers (21 or more cigarettes per day). 11.Subjects who have been diagnosed with dry mouth. 12.Subjects who have had more than 400 mL of blood drawn within 12 weeks prior to the start of intake, or more than 200 mL of blood drawn during the previous observation period. 13.Subjects who have been deemed unsuitable as study participants by the principal investigator or sub-investigator based on their background, physical examination, blood pressure, pulse rate, and clinical test results.

发起方